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Summary
 
Interleukin (IL)-8, a C-X-C chemokine, activates integrin-mediated adhesion of neutrophils.
Presentation of IL-8 on the endothelial cell surface may promote leukocyte extravasation. We
found that cultured human microvascular endothelial cells from the intestine (HIMEC) and
from nasal polyps (PMEC), but not human umbilical vein endothelial cells (HUVEC), con-
tained IL-8 in intracellular granules that coexpressed von Willebrand factor (vWf). This obser-
vation was corroborated by the immunohistochemical observation of double-positive granules
(IL-8
 
1
 
vWf
 
1
 
) in vessels of small and large intestine, nasal mucosa, and skin, whereas umbilical
cords revealed no endothelial IL-8. After treatment of HIMEC or PMEC with histamine or
thrombin, a dramatic increase in supernatant IL-8 concentration was observed within 3 min,
whereas no increase in IL-8 was detected in supernatants of identically treated HUVEC cul-
tures. Histamine or thrombin treatment also caused IL-8–containing granules to rapidly disap-
pear from HIMEC. In HUVEC, IL-8–containing granules were inducible by treatment with
recombinant human IL-1
 
b
 
 for 24 h; additional histamine treatment doubled IL-8 secretion
from HUVEC in the same rapid manner observed for mucosal EC. These data suggested that
IL-8 prestored in microvascular endothelial cells may provide a rapid pathway for specific acti-
vation of neutrophil adhesion at sites of acute inflammation.
Key words: chemokine • inﬂammation • leukocyte adhesion • neutrophil recruitment • 
secretion
 
A
 
dhesion of neutrophils to endothelial cells (EC) is an
early, requisite event in the acute inflammatory re-
sponse. Such binding of neutrophils can be rapid and tran-
sient, occurring within minutes under some conditions, or
developing over hours depending on the factors that incite
inflammation or tissue damage. According to the current
paradigm, these interactions involve a stepwise engagement
of juxtaposed neutrophil- and EC-adhesion molecules, first
selectins and their counterreceptors, which mediate neutro-
phil tethering and rolling, then 
 
b
 
2
 
-integrins and immunoglo-
bulin-like intercellular adhesion molecules, which mediate
firm neutrophil adhesion (1–3). The most rapid recruitment
of neutrophils may be initiated by P-selectin, a transmem-
brane glycoprotein constitutively present in the Weibel-
Palade bodies of EC (4, 5); this selectin is translocated within
minutes to the cell surface membrane after stimulation with a
number of secretagogues, including thrombin or histamine
(6). On the EC surface, P-selectin supports the initial rolling
of neutrophils both in vitro (7) and in vivo (8, 9). However,
this rolling is of a transient nature, and firm adhesion through
integrin binding requires neutrophil activation through G
 
a
 
i
 
-
linked receptors (7, 10, 11). Such activation can be accom-
plished by broadly acting leukocyte activators (3, 12) such as
platelet-activating factor (PAF [13, 14]) or by activators that
are more specific for neutrophils, such as the chemotactic
cytokine (chemokine) IL-8 (15–18).
In fact, the entire process of inflammatory neutrophil re-
cruitment can be emulated in vivo
 
 
 
by injection of IL-8 into
the tissues (19–22). Moreover, neutrophil influx is severely
impaired after intraperitoneal injection of thioglycollate in
mice deficient in the IL-8 receptor homologue (23). How-
ever, it has been noted that soluble chemoattractant gradi-
ents cannot persist on the blood–EC interface; they are
likely to be washed away by the blood flow (24–26).
Therefore, the observation of in situ binding of IL-8 to EC
in human skin (27), and the enhanced ability of immobi-
lized chemokines to attract and activate leukocytes in vitro
(28), led to the theory that chemokines bound to the EC
membrane may effectively promote leukocyte–EC adhe-
sion in vivo. Furthermore, tissue-derived IL-8 can be trans-
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cytosed and presented on the surface of EC (29), but such
translocation of IL-8 requires its release or production in
the tissue and its subsequent transport to the EC surface.
Here we describe that IL-8 can also be released within
minutes from Weibel-Palade bodies in resting (i.e., not
previously exposed to proinflammatory reagents in vitro)
cultured human intestinal microvascular EC (HIMEC) and
nasal polyp–derived microvascular EC (PMEC) after stim-
ulation with histamine or thrombin. Such storage of a
chemokine may be a novel principle in the biology of leu-
kocyte adhesion that would serve to rapidly increase local
chemokine concentrations at the EC surface and enable a
higher level of specificity than that provided by classical
chemoattractants such as PAF.
 
Materials and Methods
 
Reagents
 
Cytokines and Cell Culture Reagents.
 
Recombinant human
(rh)IL-1
 
b
 
 and rh basic fibroblast growth factor were obtained
from R&D Systems Ltd. (Abingdon, UK). MCDB 131, cyclo-
heximide, dibutyryl cAMP, histamine, thrombin, epidermal
growth factor, and hydrocortisone were from Sigma Chemical
Co. (St. Louis, MO), and Endothelial–SFM, FCS, and gentami-
cin from Life Technologies Ltd. (Paisley, UK).
 
Primary Antibodies and Secondary Conjugates.
 
mAbs to human
IL-8 (clone NAP-1, IgG1; and clone LS04/2A2, IgG1) were gifts
from Dr. C. Svanborg (University of Lund, Lund, Sweden) and Dr.
C. Mackay (LeukoSite, Inc., Cambridge, MA), respectively; rabbit
anti–human von Willebrand factor (vWf, IgG fraction) and FITC-
labeled swine anti–rabbit IgG conjugate were purchased from Dako-
patts A/S (Glostrup, Denmark); biotinylated horse anti–mouse IgG
was from Vector Laboratories, Inc. (Burlingame, CA), and strepta-
vidin–Texas Red conjugate from GIBCO BRL (Gaithersburg, MD).
 
Cell Culture
 
HIMEC and PMEC were isolated from segments of small in-
testine or from nasal polyps and cultured as described (30, 31). In
brief, cells were dispersed from minced tissue by collagenase/dis-
pase treatment, plated, and grown to confluence in Endothelial–
Figure 1. Expression of IL-8 and vWf in resting HIMEC. Two-color immunofluorescence staining for IL-8 (a, c, and e) and vWf (b, d, and e) on
monolayer culture. Red, IL-8 staining; green, vWf staining; yellow, colocalized IL-8 and vWf staining. Scale bars, 10 mm.
Figure 2. Effect of histamine
on release of IL-8. Time course
of IL-8 release from confluent
EC cultures in the presence (open
circles) or absence (filled circles) of
histamine (0.1 mM). ELISA
measurements in supernatant
fluid, representative results from
one of four similar experiments
(mean 6 SD of triplicate wells). 
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SFM containing 2.5% FCS, 1 
 
m
 
g/ml hydrocortisone, 0.5 mM
dibutyryl cAMP, 50 
 
m
 
g/ml gentamicin, and 0.25 
 
m
 
g/ml ampho-
tericin-B. EC were selected from primary cultures by using para-
magnetic beads armed either with mAb to CD31 (positive selec-
tion) or with mAb to CD44 (negative selection [31]). HIMEC
and PMEC were subsequently maintained in MCDB 131 as de-
scribed for HUVEC (see below).
HUVEC were isolated as described by Jaffe et al. (32) and cul-
tured in MCDB 131 containing 7.5% FCS, 10 ng/ml epidermal
growth factor, 1 
 
m
 
g/ml hydrocortisone, 50 
 
m
 
g/ml gentamicin, and
0.25 
 
m
 
g/ml amphotericin-B. All cultures were used at passage lev-
els 1–8, were uniformly positive for vWf, and contained 
 
,
 
1% con-
taminating cell types determined as described elsewhere (30, 31).
 
ELISA Experiments
 
HIMEC, PMEC, and HUVEC were grown to confluence in
96-well trays (Becton Dickinson, San Jose, CA). At the start of
the experiment, resting or IL-1
 
b
 
–activated (100 U/ml, 24 h) EC
monolayers were washed twice. Cells were subsequently incu-
bated at 37
 
8
 
C in culture medium with or without histamine (0.1
mM) or thrombin (3 U/ml). Cell culture supernatant fluids were
analyzed for IL-8 with an ELISA kit according to the recommen-
dations of the manufacturer (R&D Systems Ltd.). In our hands,
this assay provided an analytical sensitivity of 51 pg/ml.
 
Immunocyto/histochemistry
 
Confluent monolayers of EC grown on LabTek chamber slides
(Nunc, Inc., Roskilde, Denmark) were fixed (10 min, pH
 
 5 
 
7.4)
in 0.5% periodate-lysine-paraformaldehyde (33) or in 4% para-
formaldehyde (PFA). Tissue specimens from histologically normal
small (
 
n
 
 5 
 
2) and large (
 
n
 
 5 
 
2) intestine, skin (
 
n
 
 5 
 
2), nasal mu-
cosa (
 
n
 
 5 
 
3), and umbilical cord (
 
n
 
 5 
 
1) were snap frozen and
stored at 
 
2
 
70
 
8
 
C. Cryosections were cut at 4 
 
m
 
m and fixed in 4%
PFA for 5 min at 23
 
8
 
C. All subsequent incubation steps except
the last washing step were performed with 0.1% saponin for per-
meabilization. Cell monolayers or tissue sections were first incu-
bated with mAb to IL-8 (10 
 
m
 
g/ml) for 1 h or overnight, respec-
 
tively; then with rabbit IgG anti–human vWf (1:1,400) combined
with biotinylated horse anti–mouse IgG (1:250) for 1 h; and fi-
nally with streptavidin–Texas red conjugate (1:200) combined
with FITC-labeled swine anti–rabbit IgG (1:50) for 0.5 h. Nega-
tive controls were incubated with irrelevant isotype- and concen-
tration-matched primary antibodies. All fixations and incubations
took place at room temperature.
The immunostained slides were examined and analyzed with a
confocal laser scanning microscope (MRC 600; Bio-Rad Labora-
tories Ltd., Hemel Hempstead, UK) or a fluorescence microscope
(model E800; Nikon, Tokyo, Japan) equipped with a cooled
CCD camera (Hamamatsu Photonics K.K., Hamamatsu City, Ja-
pan).
 
Results
 
Resting Microvascular EC but not HUVEC Contain IL-8
 
1
 
Granules.
 
In contrast to HUVEC, unstimulated HIMEC
(Fig. 1, 
 
a
 
, 
 
c
 
, and 
 
e
 
) and PMEC (data not shown) contained
IL-8 in intracellular vesicle–like granules as revealed by
staining with mAbs LS04/2A2 and NAP-1. Staining of
nonpermeabilized monolayers revealed no reactivity (data
not shown). The observed subcellular localization of IL-8
was similar to that described for vWf (34) and P-selectin (4,
5), which both are stored in Weibel-Palade bodies. There-
fore, we performed paired immunostaining with an anti-
body to vWf (Fig. 1, 
 
b
 
, 
 
d
 
, and 
 
e
 
) and found coexpression of
the two proteins in most granules. In addition, mAb NAP-1
revealed perinuclear IL-8 reactivity compatible with its
presence in the Golgi apparatus (data not shown), as also
reported for other cytokines (35), but this staining pattern
was not observed with mAb LS04/2A2.
 
Rapid Secretion of IL-8 from Microvascular EC Is Induced by
Histamine or Thrombin.
 
We observed a higher constitutive
secretion of IL-8 into the culture supernatant in unstimu-
lated HIMEC and PMEC than in HUVEC (Fig. 2, and
data not shown). However, treatment of HIMEC (Fig. 2)
and PMEC (data not shown) monolayers with histamine
(0.1 mM) or thrombin (3 U/ml, data not shown) more
than doubled the level of IL-8 over unstimulated cultures
within 5 min (Fig. 2). Consistent with the lack of detect-
able granule-associated IL-8 in HUVEC, these agents had
no effect on IL-8 levels (Fig. 2). To exclude enhanced pro-
tein synthesis as a possible explanation for the increased lev-
els of IL-8 in the supernatant, HIMEC and HUVEC were
incubated with the protein synthesis inhibitor cyclohexi-
mide (1 mg/ml) for 24 h before histamine stimulation. De-
Figure 3. Effect of cyclohex-
imide on histamine-induced
IL-8 secretion. Confluent EC
were incubated in the absence
(white bars) or presence (black
bars) of cycloheximide (Cx; 1
mg/ml, 24 h) and washed twice
in fresh medium before his-
tamine stimulation (0.1 mM, 15
min). ELISA measurements of
IL-8 in EC culture supernatants. Representative results from one of three
similar experiments (mean 6 SD of triplicate wells).
Figure 4. IL-81 vesicles disap-
pear rapidly after activation with
histamine. IL-8 expression in the
absence (a) or presence (b) of his-
tamine (0.1 mM, 15 min). Immu-
nofluorescence staining (clone
NAP-1) of fixed and permeabi-
lized HIMEC culture (scale
bars, 10 mm). 
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spite further reduction of the low level of constitutive IL-8
secretion observed in both cell types, cycloheximide had
no effect on the amount of IL-8 released in response to his-
tamine (Fig. 3).
 
IL-8
 
1
 
 Granules Disappear Rapidly after Stimulation with
Histamine.
 
Immunocytochemical staining of resting and
histamine-stimulated HIMEC (Fig. 4) revealed that the ob-
served increase of secreted IL-8 was accompanied by disap-
 
pearance of IL-8
 
1
 
 granules, most apparent after 15 min
(Fig. 4 
 
b
 
). Double staining also revealed a reduction of
vWf
 
1
 
 granules after histamine stimulation (data not shown).
 
Microvascular EC, but not HUVEC, Contain IL-8
 
1
 
 Gran-
ules In Situ.
 
This disparity between small vessel–derived
EC and HUVEC observed in vitro
 
 
 
was substantiated by
immunohistochemical detection of IL-8 in small vessels of
small intestine (Fig. 5, 
 
a
 
 and 
 
c
 
) but not in EC of the umbilical
vein (data not shown). The IL-8 staining of these vessels was
observed in granules that costained for vWf (Fig. 5, 
 
b
 
 and 
 
c
 
).
Small vessels of the normal skin, nasal mucosa, and large in-
testine also contained IL-8
 
1
 
 granules (data not shown).
 
IL-8
 
1
 
 Granules Are Inducible in HUVEC.
 
After activa-
tion with rhIL-1
 
b
 
 (100 U/ml) for 24 h, IL-8
 
1
 
 granules co-
expressing vWf appeared in HUVEC (data not shown),
and strongly elevated IL-8 secretion levels were observed
for both HIMEC and HUVEC after such treatment (Fig.
6). In HIMEC, IL-1 treatment enhanced the staining in-
tensity of IL-8
 
1
 
 granules (data not shown). We next tested
if histamine would effect the release of IL-8 from cytokine-
activated EC and found almost doubling of the level of re-
leased IL-8 in both cell types within 15 min (Fig. 6).
 
Discussion
 
This study reports that the chemokine IL-8 is stored in
resting microvascular EC and can be rapidly released to the
luminal EC surface after activation by secretagogues such as
histamine and thrombin. This availability may play a crucial
role in providing rapid recruitment of neutrophils because
prestored P-selectin, which is also made available at the en-
dothelial surface after such activation (6), merely permits
transient rolling of neutrophils (7). Subsequent firm adhe-
sion appears to require the activation of 
 
b
 
2-integrins,
which can be achieved by stimulation of leukocytes with
broadly acting classical chemoattractants or with leukocyte
type-specific chemokines affording a higher level of speci-
ficity (7, 10, 11). The classical chemoattractant PAF is the
only known adhesion-activating factor that can be made
available at the endothelial surface within minutes of EC
stimulation (18). However, PAF activates several types of
leukocytes that can both roll on P-selectin and adhere
firmly to integrin counterreceptors on EC (3, 12, 14). On
the other hand, the ability of IL-8 to activate integrin-
mediated adhesion appears restricted to neutrophils, and its
Figure 5. In situ detection of IL-8 in human small intestine. EC in sub-
mucosal vein of human jejunum stained for IL-8 (a and c) and vWf (b and
c). Red, IL-8 staining; green, vWf staining; yellow, colocalized IL-8 and
vWf staining. Arrows, Double-positive granules; note variability of stain-
ing intensity for the two proteins. Two-color immunofluorescence stain-
ing of fixed and permeabilized tissue sections (scale bars, 20 mm).
Figure 6. Effect of histamine
on release of IL-8 from IL-1b–
activated EC. Confluent EC
monolayers were activated with
rhIL-1b (100 U/ml, 24 h) and
washed twice in fresh medium
before histamine stimulation (0.1
mM, 15 min). ELISA measure-
ments of IL-8 in EC culture su-
pernatants, representative results
from one of four similar experi-
ments (mean 6 SD of triplicate
wells).1755 Utgaard et al. Brief Definitive Report
rapid secretion from previously resting microvascular EC as
described here may provide a higher level of specificity in
the earliest phases of neutrophil recruitment.
Our data convincingly show that human microvascular
EC in intestinal and airway mucosa, as well as in skin, con-
tain IL-8 in intracellular granules that also contain vWf,
clearly indicating that these granules are Weibel-Palade
bodies (34). Indeed, immunoelectron microscopy of IL-1–
activated HUVEC revealed IL-8 in the Weibel-Palade
bodies (36), thus supporting our conclusion. Moreover,
histamine or thrombin induced a rapid release of IL-8 from
HIMEC and PMEC, in a time course virtually identical to
that described for translocation of P-selectin to the EC sur-
face (6), whereas resting HUVEC failed to release IL-8
above background levels. The observed level of IL-8 re-
leased to the culture supernatant probably underestimated
the true concentration obtainable in the microenvironment
between the surface membranes of EC and adhering leuko-
cytes. First, EC in vivo possess binding sites for IL-8 (24)
that are grossly lost upon culture of HIMEC (our unpub-
lished data) or EC from other tissue sources (37, 38).
Second, the recently described presentation of transcytosed
IL-8 on EC microvilli (29), paralleling that of a4b7 and
L-selectin on leukocytes (39, 40), raises the interesting
question as to whether prestored endothelial IL-8 may be
presented in the same manner, thereby enhancing the
availability of IL-8 to its leukocyte receptors. On the other
hand, in vitro studies have suggested that as few as 300
molecules of IL-8 per mm2 are sufficient for activation of
adhesion to occur (Campbell, J.J., personal communica-
tion).
The constitutive secretion of IL-8 measured at various
time points also indicated a difference in the resting state
between microvascular EC and HUVEC, possibly pointing
to a fundamental biological difference between small and
large vessels. However, after activation with rhIL-1b, both
HUVEC and HIMEC secreted elevated levels of IL-8; in
this case, IL-81 vesicles appeared in HUVEC, as also de-
scribed by Wolff et al. (36). The biological significance of
the latter finding is uncertain, but it may reflect a common
sorting signal in the IL-8 sequence, whereas the absence of
IL-8 inside unstimulated HUVEC might merely reflect the
low constitutive level of IL-8 synthesis. To this end, it is
interesting to note that the microvascular EC described in
this study all derive from organs or tissues that border the
external environment and may thus experience chronic in-
flammatory stimulation, possibly resulting in a higher level
of constitutive IL-8 expression. The molecular mechanisms
that allow such constitutive differences to persist over
weeks in vitro remain to be elucidated.
In conclusion, we describe a novel mechanism by which
IL-8 can be made available at the EC surface within min-
utes of activation. Such presentation may provide a rapid
pathway for specific activation of neutrophil adhesion at
sites of acute inflammation.
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